Brief: Nuvectis Pharma Says Michael Carson Is Replacing Uri Ben-Or Who Served As Interim Chief Financial Officer
22/03/2022 15:15
March 22 (Reuters) - Nuvectis Pharma Inc NVCT.O :
* NUVECTIS PHARMA - MICHAEL CARSON IS REPLACING URI BEN-OR
WHO
SERVED AS INTERIM CHIEF FINANCIAL OFFICER
Further company coverage: NVCT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Nuvectis Pharma
See all newsNuvectis Pharma Inc reports results for the quarter ended June 30 - Earnings Summary
Nuvectis Pharma Inc expected to post a loss of 26 cents a share - Earnings Preview
Brief: Ciprocopan (NXP100) Receives Marketing Approval In China For The Treatment Of Patients With PNH Previously Untreated With Complement Inhibitors
U.S. STOCKS ON THE MOVE-Chip stocks, Unicycive, Roblox
U.S. STOCKS ON THE MOVE-AMD, Roblox, Olin